Home › Funds › Royce & Associates › OGN

Royce & Associates position in OGN

ORGANON & CO · Health Care

Latest position (Q2 2026)93.58K sh
Reported value held$1.27M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeHold

Quarter by quarter

QuarterSharesValueChange
Q3 2021 520.46K $17.07M New
Q4 2021 513.05K $15.62M Reduce
Q1 2022 402.11K $14.05M Reduce
Q2 2022 383.81K $12.95M Reduce
Q3 2022 364.01K $8.52M Reduce
Q4 2022 352.75K $9.85K Reduce
Q1 2023 289.36K $6.81K Reduce
Q2 2023 364.44K $7.58M Add
Q3 2023 534.07K $9.27M Add
Q4 2023 628.67K $9.07M Add
Q1 2024 643.07K $12.09M Add
Q2 2024 672.34K $13.92M Add
Q3 2024 703.09K $13.45M Add
Q4 2024 869.39K $12.97M Add
Q1 2025 846.77K $12.61M Reduce
Q2 2025 752.92K $7.29M Reduce
Q3 2025 56.51K $603.47K Reduce
Q4 2025 59.88K $429.32K Add
Q1 2026 93.58K $560.52K Add
Q2 2026 93.58K $1.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding OGN

All OGN fund holders →